HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glibenclamide inhibits NLRP3 inflammasome-mediated IL-1β secretion in human trophoblasts.

Abstract
Infection-associated pregnancy complications cause premature delivery. Caspase-1 is involved in the maturation of interleukin (IL)-1β, which is activated by the NLRP3 inflammasome. To characterize the significance of the NLRP3 inflammasome pathway in the placenta, the effects of activators and inhibitors on NLRP3-related molecules were examined using isolated primary trophoblasts. Caspase-1 and IL-1β mRNA expression was markedly increased in response to lipopolysaccharide (LPS), a toll-like receptor (TLR)4 ligand. Treatment with the potassium ionophore nigericin significantly increased the level of activated caspase-1. Treatment with either LPS or nigericin stimulated IL-1β secretion, whereas pretreatment with the ATP-sensitive K+ channel inhibitor glibenclamide, the Rho-associated coiled-coil kinase inhibitor Y-27632, or a caspase-1 inhibitor significantly decreased nigericin-induced IL-1β secretion. In addition, dibutyryl-cAMP, which induces trophoblast differentiation, decreased expression of NLRP3, caspase-1, and IL-1β. These findings suggest that trophoblasts can secrete IL-1β through the NLRP3/caspase-1 pathway, which is suppressed by glibenclamide, and that the TLR4-mediated NLRP3 inflammasome pathway is more likely to be stimulated in undifferentiated than differentiated trophoblasts. Our data support the hypothesis that inhibition of the NLRP3 inflammasome can suppress placental inflammation-associated disorders.
AuthorsKazuhiro Tamura, Gen Ishikawa, Mikihiro Yoshie, Wakana Ohneda, Akihito Nakai, Toshiyuki Takeshita, Eiichi Tachikawa
JournalJournal of pharmacological sciences (J Pharmacol Sci) Vol. 135 Issue 2 Pg. 89-95 (Oct 2017) ISSN: 1347-8648 [Electronic] Japan
PMID29056256 (Publication Type: Journal Article)
CopyrightCopyright © 2017 The Authors. Production and hosting by Elsevier B.V. All rights reserved.
Chemical References
  • Amides
  • Inflammasomes
  • Interleukin-1beta
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • NLRP3 protein, human
  • Potassium Channel Blockers
  • Potassium Ionophores
  • Pyridines
  • Y 27632
  • Bucladesine
  • Caspase 1
  • Glyburide
Topics
  • Amides (pharmacology)
  • Bucladesine (pharmacology)
  • Caspase 1 (metabolism, physiology)
  • Cell Differentiation (drug effects)
  • Cells, Cultured
  • Female
  • Glyburide (pharmacology)
  • Humans
  • Inflammasomes (physiology)
  • Interleukin-1beta (metabolism)
  • NLR Family, Pyrin Domain-Containing 3 Protein (metabolism, physiology)
  • Potassium Channel Blockers (pharmacology)
  • Potassium Ionophores (pharmacology)
  • Pregnancy
  • Pyridines (pharmacology)
  • Trophoblasts (cytology, metabolism)
  • U937 Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: